Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 16.
doi: 10.1007/s00464-025-12061-0. Online ahead of print.

Efficacy and safety of endoscopic submucosal dissection for pyloric neoplasms

Affiliations

Efficacy and safety of endoscopic submucosal dissection for pyloric neoplasms

Shao-Bin Luo et al. Surg Endosc. .

Abstract

Background and aims: Although endoscopic resection is widely accepted for pyloric lesions, endoscopic submucosal dissection (ESD) of pyloric neoplasms remains technically challenging. The study aimed to assess the efficacy and safety of ESD for pyloric neoplasms.

Methods: From June 2011 to August 2024, we retrospectively analyzed 103 patients with pyloric neoplasms who underwent ESD at the Endoscopy Center of Zhongshan Hospital. Clinical data,‌ including patient demographics, procedural outcomes, and follow-up results, were collected.

Results: Among 103 lesions, there were 36 prepyloric neoplasms, 49 pyloric neoplasms and 18 postpyloric neoplasms. The median lesion size was 31 mm (range 10-85 mm). The postpyloric group showed longer procedure duration (32 min vs. 39 min vs. 46 min, P = 0.029) and lower rate of en bloc resection (100.0% vs. 95.9% vs. 83.3%, P = 0.026) compared with the prepyloric group and pyloric group. No patients required conversion to open surgery. After procedure, delayed bleeding occurred in ‌one patient each‌ from the prepyloric and pyloric groups. During a median follow-up of 25 months (range: 6-81 months), only ‌one recurrence‌ (pyloric group) was observed. Post-ESD pyloric stenosis developed in 5 patients, all of whom achieved ‌symptomatic relief‌ through endoscopic balloon dilation (EBD) without complications.

Conclusions: ESD is a feasible and safe treatment for pyloric neoplasms. Additionally, EBD appears to be a safe and effective ‌therapeutic approach for post-ESD pyloric stenosis.

Keywords: Endoscopic balloon dilation; Endoscopic submucosal dissection; Pyloric neoplasms; Pyloric stenosis.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Dr. Shao-Bin Luo, Zu-Qiang Liu, Li Wang, Yi-Qun Zhang, Ming-Yan Cai, Quan-Lin Li, and Ping-Hong Zhou have no conflict or financial ties to disclosure.

References

    1. Abe N, Takeuchi H, Ooki A, Nagao G, Masaki T, Mori T, Sugiyama M (2013) Recent developments in gastric endoscopic submucosal dissection: towards the era of endoscopic resection of layers deeper than the submucosa. Dig Endosc 25(Suppl 1):64–70 - DOI - PubMed
    1. Pezhouh MK, Park JY (2015) Gastric pyloric gland adenoma. Arch Pathol Lab Med 139:823–826 - DOI - PubMed
    1. Akasaka T, Nishida T, Tsutsui S, Michida T, Yamada T, Ogiyama H, Kitamura S et al (2011) Short-term outcomes of endoscopic submucosal dissection (ESD) for early gastric neoplasm: multicenter survey by osaka university ESD study group. Dig Endosc 23:73–77 - DOI - PubMed
    1. Tsuji Y, Ohata K, Sekiguchi M, Ito T, Chiba H, Gunji T, Yamamichi N et al (2011) An effective training system for endoscopic submucosal dissection of gastric neoplasm. Endoscopy 43:1033–1038 - DOI - PubMed
    1. Chiba H, Ohata K, Tachikawa J, Yamada K, Kobayashi M, Okada N, Arimoto J et al (2022) The feasibility and safety of endoscopic submucosal dissection of gastric lesions larger than 5 cm. Gastric Cancer 25:1031–1038 - DOI - PubMed

LinkOut - more resources